Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00201253 · ClinicalTrials.gov registry record
Expression of Tuberculosis in the Lung
A clinical trial of Tuberculosis, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 40
- Enrollment target
- 2
- Study locations
NCT00201253: Completed study of Tuberculosis, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00201253 is a study of Tuberculosis that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 40 participants, below the 933-participant average among 29 other Tuberculosis trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00201253, a study of Tuberculosis, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess lung immune responses in patients with active pulmonary tuberculosis (TB) and in healthy control persons who are exposed to Mycobacterium tuberculosis in households of patients with TB or who are unexposed.
Conditions Studied
Interventions
- OTHER Bronchoalveolar lavages and venipunctures only
Study Locations (2)
New Jersey
- UMDNJ-New Jersey Medical School - Newark
Other
- Instituto Nacional de Enfermedades Respiratorias (INER) - Mexico City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2000-09 |
| Est. Completion | 2008-06 |
What the finished NCT00201253 record still lists
NCT00201253 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 933-participant average among 29 other Tuberculosis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Tuberculosis appearing as the primary indexed condition, and to 1 intervention - of which Bronchoalveolar lavages and venipunctures only is the first listed.
NCT00201253 reports a single indexed study location in New Jersey, Other.
Frequently Asked Questions
What is clinical trial NCT00201253 about?
NCT00201253 is a clinical study titled "Expression of Tuberculosis in the Lung". The purpose of this study is to assess lung immune responses in patients with active pulmonary tuberculosis (TB) and in healthy control persons who are exposed to Mycobacterium tuberculosis in households of patients with TB or who are unexposed.
What is the current status of trial NCT00201253?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2000-09. Estimated completion is 2008-06.
What conditions does trial NCT00201253 study?
This clinical trial studies the following conditions: Tuberculosis.
What interventions are being tested in trial NCT00201253?
The interventions under investigation include: Bronchoalveolar lavages and venipunctures only (OTHER).
Who is sponsoring clinical trial NCT00201253?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00201253 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00201253's enrollment target sits among peer trials
40 25th of 29 higher than 5 of 29 other Tuberculosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tuberculosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
RECRUITING
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
ACTIVE NOT RECRUITING
-
Gene Expression in HIV and Tuberculosis Co-infection
COMPLETED
-
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
COMPLETED · Phase 1
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia